章军｜厦门大学｜学者主页

2026

Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human VH1-2-rearranging mouse models

Himanshu Batra, Sai Luo, K. Saunders, Jaclyn S. Higgins, F. Jian, Jun Zhang, Md Golam Kibria, G. Jonaid, Qing Zhou, A. Eaton, Ken Cronin, Michael L. Mallory, Melissa M Mattocks, R. Edwards, R. Parks, Esther M. Lee, Adam Yongxin Ye, Aimee Chapdelaine Williams, Geeyoun Jung, K. Mansouri, S. Alam, D. Montefiori, Ming Tian, R. Baric, Y. Cao, B. Haynes, Bing Chen, Frederick W. Alt

Proceedings of the National Academy of Sciences of the United States of America

精选作品

期刊论文

Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human VH1-2-rearranging mouse models

Reoviridae-derived short trimerization domain for stabilizing homo-trimerization of vaccine immunogens and therapeutic proteins

Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma

Substantial spillover burden of rat hepatitis E virus in humans

A single residue switch mediates the broad neutralization of Rotaviruses

Preliminary Cost-effectiveness and Cost-utility of Nasopharyngeal Carcinoma Screening with the Novel Biomarker Anti-BNLF2b Total Antibody

Novel adjuvant delivery system constructed by alum-emulsion hybrid nanoparticles with TLR9 agonists boosts vaccine immunity

SLC3A2-Mediated Lysine Uptake by Cancer Cells Restricts T-cell Activity in Hepatocellular Carcinoma

教科融合指导开展“捉虫大赛”活动——“遗传与分子生物学实验”课程教学案例解析

Microsphere integrated convective amplification sensor for all-in-one-pot detection of Mycoplasma pneumoniae

Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2

Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern China

Reviews of "Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial"

Review 1: "Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial"

Author Correction: Design of a recombinant asparaginyl ligase for site-specific modification using efficient recognition and nucleophile motifs

Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects

Design of a recombinant asparaginyl ligase for site-specific modification using efficient recognition and nucleophile motifs

Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18–45 years

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels

Tpgen: a language model for stable protein design with a specific topology structure

Distinct In Vitro and In Vivo Neutralization Profiles of Monoclonal Antibodies Elicited by the Receptor Binding Domain of the Ancestral SARS-CoV-2

Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein

Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

Structure and proposed DNA delivery mechanism of a marine roseophage

Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors

Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design

Fighting SARS-CoV-2 with structural biology methods

An Antibody from Single Human VH-rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion

Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanism

Structural and functional impact by SARS-CoV-2 Omicron spike mutations

Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2

Structures of pseudorabies virus capsids

Development of a skin- and neuro-attenuated live vaccine for varicella

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine

Development of a rapid neutralization testing system for Rhinovirus C15 based on the enzyme-linked immunospot assay

Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail

Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice

Development of a rapid neutralization assay for the detection of neutralizing antibodies against coxsackievirus B1

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: Erratum

Structural impact on SARS-CoV-2 spike protein by D614G substitution

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent

Structure of SARS-CoV-2 spike protein

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters

Sporadic hand, foot, and mouth disease cases associated with non-C4 enterovirus 71 strains in Xiamen, China, from 2009 to 2018

Elimination of human cytomegalovirus DNA degradation in urine

Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster

Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding

Cross-Species Tropism and Antigenic Landscapes of Circulating SARS-CoV-2 Variants

Distinct conformational states of SARS-CoV-2 spike protein

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

Sequential Acquisition of Human Papillomavirus Infection at Genital and Anal Sites, Liuzhou, China

Reply to Nagappa and Marimuthu

Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

Viral neutralization by antibody-imposed physical disruption